Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 982.71M | 989.56M | 957.01M | 919.78M | 852.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 982.71M | 989.56M | 957.01M | 919.78M | 852.97M |
| Cost of Revenue | 436.67M | 408.84M | 386.72M | 364.22M | 353.41M |
| Gross Profit | 546.03M | 580.72M | 570.29M | 555.56M | 499.56M |
| SG&A Expenses | 277.91M | 285.52M | 274.67M | 272.01M | 243.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -16.15M | -5.10M | -6.61M | -5.43M | -8.09M |
| Total Operating Expenses | 782.28M | 768.08M | 741.58M | 705.04M | 671.35M |
| Operating Income | 200.42M | 221.48M | 215.43M | 214.73M | 181.63M |
| Income Before Tax | 231.69M | 221.88M | 228.82M | 225.62M | 192.87M |
| Income Tax Expenses | 48.32M | 55.69M | 68.67M | 58.75M | 35.48M |
| Earnings from Continuing Operations | 183.37M | 166.19M | 160.15M | 166.87M | 157.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 762.50K | 1.12M | -10.29M | -- | -- |
| Net Income | 184.13M | 167.32M | 149.86M | 166.87M | 157.40M |
| EBIT | 200.42M | 221.48M | 215.43M | 214.73M | 181.63M |
| EBITDA | 238.61M | 277.35M | 262.88M | 260.41M | 212.57M |
| EPS Basic | 0.22 | 0.20 | 0.18 | 0.20 | 0.19 |
| Normalized Basic EPS | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 |
| EPS Diluted | 0.22 | 0.20 | 0.18 | 0.20 | 0.19 |
| Normalized Diluted EPS | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 |
| Average Basic Shares Outstanding | 833.19M | 833.31M | 832.98M | 832.64M | 832.59M |
| Average Diluted Shares Outstanding | 834.07M | 834.30M | 834.09M | 833.93M | 834.08M |
| Dividend Per Share | 0.09 | -- | -- | -- | 0.10 |
| Payout Ratio | 0.00% | 0.00% | 53.07% | -- | 0.00% |